 |
|
What will change?
-
Number of vials per package: There will be 10 vials per package instead of the previous 5 vials per package.
-
Ordering: Packages containing 5 vials will no longer be available to order in ASIIS after the transition date.
-
Package size: The package size will change to 85 mm x 51 mm x 46 mm.
-
Package National Drug Code (NDC): The carton NDC will change from 49281-0590-05 for the 5-vial carton to 49281-0590-10 for the 10-vial carton, a change that reflects the number of vials included.
|
 |
|
There is no change to:
-
MenQuadfi® formulation: The MenQuadfi® formulation will remain the same.
- MenQuadfi® indication for use: MenQuadfi® is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. MenQuadfi® is approved for use in individuals 2 years of age and older. MenQuadfi does not prevent N. meningitidis serogroup B disease.
- MenQuadfi® Current Procedural Terminology (CPT) code: 90619
|
 |
|
Timeline:
- We anticipate the transition will occur in August 2024.
- After the transition date, packages containing 5 vials will no longer be available to order in ASIIS, and subsequent orders will be shipped as packages of 10 vials.
|
Please see the full prescribing information for MenQuadfi®
|